Search

20 F 2020

Media

https://www.gsk.com/media/7971/20-f-2020.pdf

First published: 01 June 2022

GSK signs agreement to support pandemic preparedness in Europe

Media

GSK will supply Adjupanrix to 12 participating European countries.

https://www.gsk.com/en-gb/media/press-releases/gsk-signs-agreement-to-support-pandemic-preparedness-in-europe/

First published: 28 July 2022

GSK appoints Phil Dormitzer M.D., Ph.D., as Global Head of Vaccines R&D

Media

Phil Dormitzer M.D., Ph.D., will join the company as Global Head of Vaccines R&D on 3 December 2021

https://www.gsk.com/en-gb/media/press-releases/gsk-appoints-phil-dormitzer-md-phd-as-global-head-of-vaccines-rd/

First published: 30 November 2021

‘Adult vaccination plays an essential role in healthy ageing, so let’s prioritise prevention and make it a new standard of care’

Behind the science magazine

Adult immunisation can help people live longer, healthier lives and continue to make vital contributions to society

https://www.gsk.com/en-gb/behind-the-science-magazine/adult-vaccines-healthy-ageing-comment/

First published: 04 December 2023

Vaccinations are not just for children: why adult immunisation is a health and economic necessity

Behind the science magazine

As the global population ages, innovative health policy is needed to ensure adults are vaccinated against potentially dangerous diseases.

https://www.gsk.com/en-gb/behind-the-science-magazine/vaccinations-children-adult-immunisation-health-economic-benefits/

First published: 21 April 2023

The ‘tripledemic’ will hit older people hard this winter – but there are things we can all do to reduce the impact

Behind the science magazine

The flu, COVID-19, and RSV are all in circulation, raising the risk of severe infectious disease in older adults.

https://www.gsk.com/en-gb/behind-the-science-magazine/tripledemic-flu-covid-rsv-older-patients-infectious-disease/

First published: 04 January 2023

GSK opens new global vaccines R&D center in Rockville, MD, USA

Media

New state-of-the-art facility will house 450 scientists and support staff, creating up to 200 new jobs.

https://www.gsk.com/en-gb/media/press-releases/gsk-opens-new-global-vaccines-rd-center-in-rockville-md-usa/

First published: 13 December 2016

GSK announces results from 17-year retrospective study on US clinical trial diversity

Media

Study examined clinical trial diversity across 495 GSK trials involving over 100,000 participants.

https://www.gsk.com/en-gb/media/press-releases/gsk-announces-results-from-17-year-retrospective-study-on-us-clinical-trial-diversity/

First published: 06 February 2023

GSK and ViiV Healthcare to showcase advances across industry-leading infectious disease portfolio at IDWeek 2024

Media

60 abstracts to be presented across broad and growing portfolio of vaccines and medicines aimed at getting ahead of infectious disease.

https://www.gsk.com/en-gb/media/press-releases/gsk-and-viiv-healthcare-to-showcase-advances-across-industry-leading-infectious-disease-portfolio-at-idweek-2024/

First published: 10 October 2024

GSK gathers global experts to discuss role of vaccines in protecting people and the planet

Media

'Palio’ meeting to address growing threat to human health from infectious disease and its links to nature loss and climate change.

https://www.gsk.com/en-gb/media/press-releases/gsk-gathers-global-experts-to-discuss-role-of-vaccines-in-protecting-people-and-the-planet/

First published: 07 July 2022